BlackRock Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $164K | Buy |
25,830
+2,300
| +10% | +$14.6K | ﹤0.01% | 2702 |
|
|
2016
Q3 | $104K | Buy |
23,530
+984
| +4% | +$4.35K | ﹤0.01% | 2797 |
|
|
2016
Q2 | $64K | Sell |
22,546
-328
| -1% | -$931 | ﹤0.01% | 2870 |
|
|
2016
Q1 | $65K | Buy |
22,874
+9,345
| +69% | +$26.6K | ﹤0.01% | 2851 |
|
|
2015
Q4 | $140K | Sell |
13,529
-440
| -3% | -$4.55K | ﹤0.01% | 2589 |
|
|
2015
Q3 | $159K | Sell |
13,969
-142,588
| -91% | -$1.62M | ﹤0.01% | 2568 |
|
|
2015
Q2 | $2.34M | Buy |
156,557
+11,554
| +8% | +$173K | ﹤0.01% | 1459 |
|
|
2015
Q1 | $1.31M | Buy |
145,003
+1,808
| +1% | +$16.3K | ﹤0.01% | 1711 |
|
|
2014
Q4 | $1.74M | Buy |
143,195
+1,900
| +1% | +$23.1K | ﹤0.01% | 1545 |
|
|
2014
Q3 | $1.38M | Buy |
141,295
+1,095
| +0.8% | +$10.7K | ﹤0.01% | 1579 |
|
|
2014
Q2 | $1.79M | Buy |
140,200
+119,443
| +575% | +$1.52M | ﹤0.01% | 1499 |
|
|
2014
Q1 | $220K | Buy |
+20,757
| New | +$220K | ﹤0.01% | 2426 |
|